A highly sensitive bone marrow test could double survival rates for some groups of younger adults with Acute Myeloid Leukemia (AML) by helping doctors identify if they might relapse up to three months earlier.
source https://www.sciencedaily.com/releases/2025/04/250428220307.htm
The COVID‑19 pandemic exposed the load mothers carry—a burden that's still
being ignored today
-
The COVID-19 pandemic exacerbated and brought into focus the ongoing
disproportionate burden on mothers when it comes to household logistics,
child care an...
2 days ago
No comments:
Post a Comment